Defining kidney allograft benefit from successful pancreas transplant: separating fact from fiction
- 1 August 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 23 (4) , 448-453
Abstract
To define the natural history of kidney allograft loss related to recurrent diabetes following transplant, and to understand the potential benefit of pancreas transplantation upon kidney allograft survival. A postulated benefit of simultaneous pancreas kidney transplant is that, unlike kidney transplant alone, euglycemia from the added pancreas allograft may confer a nephroprotective benefit and prevent recurrent diabetic nephropathy in the renal allograft. Recent large database analyses and long-term histological assessments have been published that assist in quantifying the problem of recurrent diabetic nephropathy and answering the question of the potential benefits of euglycemia. Further data may be extrapolated from larger single-center series that follow the prognosis of early posttransplant diabetes mellitus as another barometer of risk from diabetic nephropathy and graft loss. Recurrent diabetic nephropathy following kidney transplant is a relatively rare, late occurrence and its clinical significance is significantly diminished by the competing risks of death and chronic alloimmune injury. Although there are hints of a protective effect upon kidney graft survival with pancreas transplant, these improvements are small and may take decades to appreciate. Clinical decision-making regarding pancreas transplant solely based upon nephroprotective effects of the kidney allograft should be avoided.Keywords
This publication has 39 references indexed in Scilit:
- OPTN/SRTR 2016 Annual Data Report: PancreasAmerican Journal of Transplantation, 2018
- Pancreas transplantation in older patients is safe, but patient selection is paramountTransplant International, 2016
- Optimizing Pancreas Transplantation Outcomes in Obese RecipientsTransplantation, 2015
- Revisiting Multi-Organ Transplantation in the Setting of ScarcityAmerican Journal of Transplantation, 2014
- Simultaneous Pancreas-Kidney Versus Deceased Donor Kidney Transplant: Can a Fair Comparison be Made?Transplantation, 2009
- Metabolic Control Improves Long-Term Renal Allograft and Patient Survival in Type 1 DiabetesJournal of the American Society of Nephrology, 2008
- Incidence of End-stage Renal Disease in Patients With Type 1 DiabetesJAMA, 2005
- Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic NephropathyJAMA, 2003
- Magnitude of end-stage renal disease in IDDM: A 35 year follow-up studyKidney International, 1996
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993